A biomaterial is a substance that has been created to interact with biological systems for a medical purpose, either diagnostic or therapeutic. Emerging advanced biomaterials, such as hydrogels, films, micro/nanofibers, and particles, have recently shown significant promise for use as cell/drug carriers for local drug delivery and biomimetic scaffolds for future regeneration therapies.
Any device made out of biological components is referred to as a biodevice. More efficient, concurrent design of materials and components to meet specified performance requirements, the ability to prioritise models and computational methods by the degree of utility in design, are all potential benefits of this systems approach.
Tissue engineering is a biomedical engineering discipline that restores, maintains, improves, or replaces various types of biological tissues by combining cells, engineering, materials technologies, and appropriate biochemical and physicochemical parameters.
Tibial inserts in total knee prostheses are designed to replicate the mechanical properties of native articular cartilage by ensuring load distribution, stress absorption, and low-friction…
Our science grope created LitAr polymer-salt material, Hydroxyapatite containing 80-85%; biopolymer - 15-20% and successfully used it for treatment of different complex diseases such as human bone…
High quality materials in the nanosize and based-platforms have advantages over conventional methods due to feasibility of tailoring and tuning the desired properties to produce enhanced uniform…
Nanomaterials have been widely tested in vitro and in small order animal studies for decades. Results have shown greater tissue growth, decreased bacteria growth, and inhibited inflammation. However…
Bioceramics intended for replacement of failure bone and dentines have two important characteristics: the biocompatibility and their ability to absorb at a rate similar to bone growth. Calcium…
Chronic wounds such as diabetic ulcers are injuries that do not repair properly, they usually occur in up to 25% of diabetic patients and their complications can cause amputations or death. An…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Advanced Bio-Materials, Bio-devices and Tissue Engineering work, reviewed by the scientific committee.
Meet materials researchers, engineers, and academics from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Advanced Bio-Materials, Bio-devices and Tissue Engineering research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Advanced Bio-Materials, Bio-devices and Tissue Engineering track is a dedicated stream within Materials 2027 covering the latest research, methods, and applications in Advanced Bio-Materials, Bio-devices and Tissue Engineering. It brings together researchers, engineers, and academics for oral presentations, posters, and discussion.
Materials researchers, engineers, educators, doctoral students, and R&D leaders with an interest in Advanced Bio-Materials, Bio-devices and Tissue Engineering are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. Materials 2027 is a hybrid conference — attend the Advanced Bio-Materials, Bio-devices and Tissue Engineering track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
